Credit Suisse analyst Erin Wilson Wright raised the price target on Charles River Labs (NYSE: CRL) to $301.00 (from $259.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Charles River Labs (CRL) PT Raised to $325 at JPMorgan, Following EarningsFebruary 17, 2021 12:27 PM Form 8-K CHARLES RIVER LABORATORI For: Feb 17February 17, 2021 7:31 AM Charles River Laboratories (CRL) Tops Q4 EPS by 29c, Revenues Beat; Offers FY21 EPS Guidance Above ConsensusFebruary 17, 2021 7:11 AM Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 GuidanceFebruary 17, 2021 7:08 AM Charles River Laboratories (CRL) to Acquire Cognate BioServices for $875 MillionFebruary 17, 2021 7:07 AM Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy DevelopmentFebruary 17, 2021 7:06 AM Form 4 CHARLES RIVER LABORATORI For: Feb 11 Filed by: FOSTER JAMES CFebruary 16, 2021 11:59 AM